Neurogenetic and Neuroimaging Evidence for a Conceptual Model of Dopaminergic Contributions to Obesity
- PMID: 25576324
- PMCID: PMC4474751
- DOI: 10.1177/1099800414565170
Neurogenetic and Neuroimaging Evidence for a Conceptual Model of Dopaminergic Contributions to Obesity
Abstract
As the incidence of obesity continues to rise, clinicians and researchers alike are seeking explanations for why some people become obese while others do not. While caloric intake and physical activity most certainly play a role, some individuals continue to gain weight despite careful attention to these factors. Increasing evidence suggests that genetics may play a role, with one potential explanation being genetic variability in genes within the neurotransmitter dopamine pathway. This variability can lead to a disordered experience with the rewarding properties of food. This review of literature examines the extant knowledge about the relationship between obesity and the dopaminergic reward pathways in the brain, with particularly strong evidence provided from neuroimaging and neurogenetic data. Pubmed, Google Scholar, and Cumulative Index to Nursing and Allied Health Literature searches were conducted with the search terms dopamine, obesity, weight gain, food addiction, brain regions relevant to the mesocortical and mesolimbic (reward) pathways, and relevant dopaminergic genes and receptors. These terms returned over 200 articles. Other than a few sentinel articles, articles were published between 1993 and 2013. These data suggest a conceptual model for obesity that emphasizes dopaminergic genetic contributions as well as more traditional risk factors for obesity, such as demographics (age, race, and gender), physical activity, diet, and medications. A greater understanding of variables contributing to weight gain and obesity is imperative for effective clinical treatment.
Keywords: BMI; dopamine; genetics; obesity.
© The Author(s) 2015.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures

Similar articles
-
Dopamine signaling in food addiction: role of dopamine D2 receptors.BMB Rep. 2013 Nov;46(11):519-26. doi: 10.5483/bmbrep.2013.46.11.207. BMB Rep. 2013. PMID: 24238362 Free PMC article. Review.
-
Differential expression of dopamine D2 and D4 receptor and tyrosine hydroxylase mRNA in mice prone, or resistant, to chronic high-fat diet-induced obesity.Brain Res Mol Brain Res. 2005 Apr 27;135(1-2):150-61. doi: 10.1016/j.molbrainres.2004.12.013. Brain Res Mol Brain Res. 2005. PMID: 15857678
-
Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats.Eur Neuropsychopharmacol. 2012 Apr;22(4):290-9. doi: 10.1016/j.euroneuro.2011.07.015. Epub 2011 Sep 1. Eur Neuropsychopharmacol. 2012. PMID: 21889317
-
Influence of feeding state on neurofunctional differences between individuals who are obese and normal weight: a meta-analysis of neuroimaging studies.Appetite. 2014 Apr;75:103-9. doi: 10.1016/j.appet.2013.12.017. Epub 2013 Dec 28. Appetite. 2014. PMID: 24380884
-
Dopamine-based reward circuitry responsivity, genetics, and overeating.Curr Top Behav Neurosci. 2011;6:81-93. doi: 10.1007/7854_2010_89. Curr Top Behav Neurosci. 2011. PMID: 21243471 Review.
Cited by
-
Enhancing Research Through the Use of the Genotype-Tissue Expression (GTEx) Database.Biol Res Nurs. 2021 Jul;23(3):533-540. doi: 10.1177/1099800421994186. Epub 2021 Feb 18. Biol Res Nurs. 2021. PMID: 33596660 Free PMC article.
-
Association between dopamine genes, adiposity, food addiction, and eating behavior in Chilean adult.Front Nutr. 2024 Sep 25;11:1466384. doi: 10.3389/fnut.2024.1466384. eCollection 2024. Front Nutr. 2024. PMID: 39385779 Free PMC article.
-
Central dopamine receptors: Radiotracers unveiling the Role of dopaminergic tone in obesity.J Mol Med (Berl). 2025 Jan;103(1):21-32. doi: 10.1007/s00109-024-02501-0. Epub 2024 Dec 4. J Mol Med (Berl). 2025. PMID: 39630278 Free PMC article. Review.
References
-
- Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ. Antipsychotic-induced weight gain: A comprehensive research synthesis. American Journal of Psychiatry. 1999;156:1686–1696. - PubMed
-
- Annerbrink K, Westberg L, Nilsson S, Rosmond R, Holm G, Eriksson E. Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men. Metabolism: Clinical and Experimental. 2008;57:708–711. - PubMed
-
- Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. Journal of Neurochemistry. 1995;65:1157–1165. - PubMed
-
- Balciuniene J, Emilsson L, Oreland L, Pettersson U, Jazin E. Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Human Genetics. 2002;110:1–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials